Northwest Biotherapeutics Company Profile (NASDAQ:NWBO)

About Northwest Biotherapeutics

Northwest Biotherapeutics logoNorthwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing immunotherapy products to treat cancer. One of the product lines (DCVax-L) is designed to cover all solid tumor cancers in which the tumors can be surgically removed. Another product line (DCVax-Direct) is designed for all solid tumor cancers. The Company's lead product, DCVax-L, is in an ongoing Phase III trial for diagnosed Glioblastome multiforme (GBM), with over 60 trial sites. Its second product, DCVax-Direct, is being studied in a 60-patient Phase I/II trial for all types of inoperable solid tumors. The 40-patient Phase I stage of the trial has been completed. The Company is working on preparations for Phase II trials of DCVax-Direct. The Company's platform technology, DCVax, uses activated dendritic cells to mobilize a patient's own immune system, including T cells, B cells and antibodies and natural killer cells, among others to attack cancer cells to attack their cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NWBO
  • CUSIP:
Key Metrics:
  • Previous Close: $0.41
  • 50 Day Moving Average: $0.419
  • 200 Day Moving Average: $0.454
  • 52-Week Range: $123,688,000.00 - $0.32
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.26
  • P/E Growth: 0.000
  • Market Cap: $51.08M
  • Outstanding Shares: 123,688,000
  • Beta: 1.75
Profitability:
  • Net Margins: -5,283.14%
  • Return on Assets: -157.12%
Debt:
  • Current Ratio: 0.04%
  • Quick Ratio: 0.04%
Additional Links:
Companies Related to Northwest Biotherapeutics:

Analyst Ratings

Consensus Ratings for Northwest Biotherapeutics (NASDAQ:NWBO) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: $0.61 (47.70% upside)

Analysts' Ratings History for Northwest Biotherapeutics (NASDAQ:NWBO)
Show:
DateFirmActionRatingPrice TargetDetails
12/15/2016S&P Equity ResearchLower Price Target$0.73 -> $0.61View Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for Northwest Biotherapeutics (NASDAQ:NWBO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/19/2014Q314($0.35)ViewN/AView Earnings Details
8/20/2014($0.29)($0.53)ViewN/AView Earnings Details
5/21/2014($0.33)($0.46)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Northwest Biotherapeutics (NASDAQ:NWBO)
Current Year EPS Consensus Estimate: $-1.850 EPS
Next Year EPS Consensus Estimate: $-1.600 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.25)($0.25)($0.25)
Q2 20161($0.29)($0.29)($0.29)
Q3 20161($0.12)($0.12)($0.12)
Q4 20161($0.12)($0.12)($0.12)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Northwest Biotherapeutics (NASDAQ:NWBO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Northwest Biotherapeutics (NASDAQ:NWBO)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Northwest Biotherapeutics (NASDAQ:NWBO)
DateHeadline
News IconFiscal Year Earnings Estimate on Northwest Biotherapeutics, Inc.(NWBO) - Money Flow Index & Trends (NASDAQ:NWBO)
www.moneyflowtrends.com - February 24 at 12:01 AM
News IconAnalytical Guide for Northwest Biotherapeutics, Inc. (NWBO), SM Energy Company (SM) Stakeholders - The USA Commerce (NASDAQ:NWBO)
www.theusacommerce.com - February 22 at 7:03 PM
News IconIs the Storm Over for Northwest Biotherapeutics, Inc (OTCMKTS ... - The Oracle Dispatch (NASDAQ:NWBO)
oracledispatch.com - February 22 at 7:03 PM
4-traders.com logoClovis Oncology : Biotech Stocks under Scanner -- ACADIA Pharma, Clovis Oncology, Galena Biopharma, and Northwest Biotherapeutics (NASDAQ:NWBO)
www.4-traders.com - February 21 at 5:56 PM
bizjournals.com logoBiotech Stocks under Scanner -- ACADIA Pharma, Clovis Oncology, Galena Biopharma, and Northwest Biotherapeutics (NASDAQ:NWBO)
www.bizjournals.com - February 21 at 5:56 PM
News IconNorthwest Biotherapeutics, Inc. (NWBO): Thoughts on the Momentum - Post Analyst (NASDAQ:NWBO)
postanalyst.com - February 20 at 9:43 AM
News IconWhich insiders are trading Northwest Biotherapeutics, Inc. (NWBO)? - Post Analyst (NASDAQ:NWBO)
postanalyst.com - February 19 at 9:39 AM
News IconChecking on Shares of Northwest Biotherapeutics, Inc. (OTCPK:NWBO) - Piedmont Register (NASDAQ:NWBO)
piedmontregister.com - February 17 at 8:18 AM
News IconForward Earnings Estimate of Northwest Biotherapeutics, Inc.(NWBO) - Highland Mirror (NASDAQ:NWBO)
www.highlandmirror.com - February 11 at 7:03 PM
bizjournals.com logoFDA lifts hold on Northwest Bio’s brain cancer immunotherapy trial (NASDAQ:NWBO)
www.bizjournals.com - February 9 at 8:01 PM
News IconCompany Watch: Viewing Levels for Northwest Biotherapeutics Inc. (NWBO) - Piedmont Register (NASDAQ:NWBO)
piedmontregister.com - February 9 at 12:55 AM
marketexclusive.com logoNORTHWEST BIOTHERAPEUTICS, INC. (OTCMKTS:NWBO) Files An 8-K Other Events (NASDAQ:NWBO)
marketexclusive.com - February 8 at 7:53 PM
investopedia.com logoNorthwest Bio Spikes on Lifting of Clinical Hold (NWBO) (NASDAQ:NWBO)
www.investopedia.com - February 7 at 9:32 PM
News IconA Look Ahead For 2 Stocks: ConocoPhillips (NYSE:COP), Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Post Analyst (NASDAQ:NWBO)
postanalyst.com - February 7 at 4:30 PM
istreetwire.com logoStocks In Action: Northwest Biotherapeutics, Inc. (NWBO), Uranium Energy Corp. (UEC), Deckers Outdoor Corporation ... - iStreetWire (NASDAQ:NWBO)
istreetwire.com - February 7 at 4:30 PM
News IconStock Watch: Viewing the Numbers for Northwest Biotherapeutics Inc. (NWBO) - Rives Journal (NASDAQ:NWBO)
rivesjournal.com - February 7 at 4:30 PM
News IconNorthwest Biotherapeutics, Inc (OTCMKTS:NWBO) Just Gave Us The Update We Were Waiting For - Insider Financial (NASDAQ:NWBO)
www.insiderfinancial.com - February 7 at 4:30 PM
investopedia.com logoFDA Lifts Hold on Northwest Bio Cancer Drug Trial (NASDAQ:NWBO)
www.investopedia.com - February 7 at 4:30 PM
News IconNorthwest Biotherapeutics, Inc. (NWBO: OTCQB) | NW Bio Announces Lifting of Clinical Hold on DCVax®-L Phase III ... - Satellite PR News (press release) (NASDAQ:NWBO)
www.satprnews.com - February 7 at 12:01 AM
reuters.com logoBRIEF-NW bio announces lifting of clinical hold on DCVax -l phase III trial by FDA (NASDAQ:NWBO)
www.reuters.com - February 6 at 7:01 PM
finance.yahoo.com logoNW Bio Announces Lifting of Clinical Hold on DCVax®-L Phase III Trial By FDA; Progression-Free Survival Events Reached; Overall Survival Events Not Yet Reached (NASDAQ:NWBO)
finance.yahoo.com - February 6 at 7:01 PM
finance.yahoo.com logo9:31 am Northwest Biotherapeutics provides a further update about the Co's Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer; announces lifting of clinical hold on DCVax-l phase III trial by FDA (NASDAQ:NWBO)
finance.yahoo.com - February 6 at 7:01 PM
News IconMA Watch on Shares of Northwest Biotherapeutics Inc. (NWBO) - Sherwood Daily (NASDAQ:NWBO)
sherwooddaily.com - February 3 at 12:52 AM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Nelson Research (NASDAQ:NWBO)
nelsonobserver.com - February 1 at 12:57 AM
News IconInvestor Arena: Keeping an Eye on Northwest Biotherapeutics Inc. (NWBO) - Sherwood Daily (NASDAQ:NWBO)
sherwooddaily.com - February 1 at 12:57 AM
News IconWhat’s Propelling Northwest Biotherapeutics, Inc (NWBO) to Decrease? The Stock Formed a Double Bottom Pattern (NASDAQ:NWBO)
randolphguide.com - January 31 at 12:38 AM
News IconNear-Term, Can This Stock Move the Needle: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Prospect Journal (NASDAQ:NWBO)
prospectjournal.com - January 30 at 7:37 PM
News IconIs This Stock Capable of a Bull Run: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Nelson Research (NASDAQ:NWBO)
nelsonobserver.com - January 30 at 7:37 PM
News IconEquity Focus: Indicator Check on Shares of Northwest Biotherapeutics Inc. (NWBO) - Sherwood Daily (NASDAQ:NWBO)
sherwooddaily.com - January 30 at 7:37 PM
News IconWhat's Propelling Northwest Biotherapeutics, Inc (NWBO) to Decrease? The Stock Formed a Double Bottom Pattern - The Randolph Guide (NASDAQ:NWBO)
randolphguide.com - January 30 at 7:37 PM
News IconNew Analyst Ratings On Northwest Biotherapeutics, Inc. (NWBO) - NewsDen (NASDAQ:NWBO)
newsden.net - January 28 at 5:21 AM
News IconBargain Hunter Investor Update on Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Prospect Journal (NASDAQ:NWBO)
prospectjournal.com - January 28 at 5:21 AM
News IconInvestors are Looking at Levels for Northwest Biotherapeutics Inc. (NWBO) - Sherwood Daily (NASDAQ:NWBO)
sherwooddaily.com - January 26 at 3:12 AM
News IconNorthwest Biotherapeutics, Inc (OTCMKTS:NWBO): What's Going On Behind The Scenes? - Insider Financial (NASDAQ:NWBO)
www.insiderfinancial.com - January 26 at 3:12 AM
4-traders.com logoNORTHWEST BIOTHERAPEUTICS, INC. (OTCMKTS:NWBO) Files An 8-K Regulation FD Disclosure (NASDAQ:NWBO)
www.4-traders.com - January 25 at 10:10 PM
News IconTrading Insight: Taking a Look at Levels for Northwest Biotherapeutics Inc. (NWBO) - Sherwood Daily (NASDAQ:NWBO)
sherwooddaily.com - January 24 at 9:04 AM
wsj.com logoFlu Case Grinds Small Biotech to a Halt (NASDAQ:NWBO)
blogs.wsj.com - January 23 at 7:17 PM
4-traders.com logoNORTHWEST BIOTHERAPEUTICS INC : Regulation FD Disclosure (form 8-K) (NASDAQ:NWBO)
www.4-traders.com - January 23 at 9:49 AM
biz.yahoo.com logoNORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure (NASDAQ:NWBO)
biz.yahoo.com - January 23 at 9:49 AM
News IconTrading Corner: Eye on Technical Levels for Northwest Biotherapeutics Inc. (NWBO) - Sherwood Daily (NASDAQ:NWBO)
sherwooddaily.com - January 21 at 6:37 AM
finance.yahoo.com logoNW Bio Presenting At Phacilitate Immunotherapy World Conference (NASDAQ:NWBO)
finance.yahoo.com - January 18 at 7:33 PM
News IconInvestor Guide: Checking on Indicators for Northwest Biotherapeutics Inc. (NWBO) - Sherwood Daily (NASDAQ:NWBO)
sherwooddaily.com - January 17 at 7:21 PM
News IconA Look at this Riveting Stock: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Prospect Journal (NASDAQ:NWBO)
prospectjournal.com - January 17 at 7:21 PM
News IconNorthwest Biotherapeutics Inc NWBO Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:NWBO)
www.bioportfolio.com - January 16 at 8:29 AM
News IconPrepping for a Big Move? Share Update on Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Prospect Journal (NASDAQ:NWBO)
prospectjournal.com - January 14 at 4:43 AM
News IconCheap Stock Alert & Update on Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Prospect Journal (NASDAQ:NWBO)
prospectjournal.com - January 14 at 4:43 AM
News IconBoom or Bust? Is there any value in Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Prospect Journal (NASDAQ:NWBO)
prospectjournal.com - January 10 at 8:50 AM
istreetwire.com logoStocks In Action: American Tower Corporation (AMT), Nordstrom, Inc. (JWN), Northwest Biotherapeutics, Inc. (NWBO) - iStreetWire (NASDAQ:NWBO)
istreetwire.com - January 10 at 8:50 AM
News IconUpside Alert: Delving into Shares of Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Prospect Journal (NASDAQ:NWBO)
prospectjournal.com - January 3 at 10:29 AM
capitalcube.com logoETFs with exposure to Northwest Biotherapeutics, Inc. : December 30, 2016 (NASDAQ:NWBO)
www.capitalcube.com - December 30 at 7:19 PM

Social

What is Northwest Biotherapeutics' stock symbol?

Northwest Biotherapeutics trades on the NASDAQ under the ticker symbol "NWBO."

Where is Northwest Biotherapeutics' stock going? Where will Northwest Biotherapeutics' stock price be in 2017?

0 analysts have issued 1 year price targets for Northwest Biotherapeutics' shares. Their forecasts range from $0.61 to $0.61. On average, they expect Northwest Biotherapeutics' stock price to reach $0.61 in the next year.

How do I buy Northwest Biotherapeutics stock?

Shares of Northwest Biotherapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Northwest Biotherapeutics stock cost?

One share of Northwest Biotherapeutics stock can currently be purchased for approximately $0.41.

Northwest Biotherapeutics (NASDAQ:NWBO) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Northwest Biotherapeutics (NASDAQ:NWBO)

Earnings History Chart

Earnings by Quarter for Northwest Biotherapeutics (NASDAQ:NWBO)

Dividend History Chart

Dividend Payments by Quarter for Northwest Biotherapeutics (NASDAQ:NWBO)

Last Updated on 2/27/2017 by MarketBeat.com Staff